Azithromycin in the Management of Patients With Acute Exacerbation of Idiopathic Pulmonary Fibrosis

• Status: Not yet recruiting
• Trial end date: 2024-06-01
• Target enrollment: 0
• Participant gender: All

Summary

The study will assess the role of using azithromycin in managing acute exacerbation of Idiopathic pulmonary fibrosis

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Assiut University
• Treatments: Azithromycin; Methylprednisolone; Methylprednisolone Acetate; Methylprednisolone Hemisuccinate; Prednisolone; Prednisolone acetate; Prednisolone hemisuccinate; Prednisolone phosphate

Criteria

Inclusion Criteria:

• Patients will be eligible for enrolment if diagnosed with Mild exacerbation of IPF and admitted to the Chest Department of Assiut University, requiring ventilator support without invasive mechanical ventilation.

Exclusion Criteria:

• Age: less than 18 years.

• Patients with any severity other than mild Acute exacerbation of IPF

• Patients with MSCT with a radiological pattern rather than UIP

• Unstable patients need mechanical ventilation or RICU admission

• Patients with end-organ failure.